Literature DB >> 13813422

The purification of human caeruloplasmin.

G CURZON, L VALLET.   

Abstract

Entities:  

Keywords:  COPPER/chemistry; PROTEINS/chemistry

Mesh:

Substances:

Year:  1960        PMID: 13813422      PMCID: PMC1204156          DOI: 10.1042/bj0740279

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


× No keyword cloud information.
  15 in total

1.  Separation and characterization of two coeruloplasmins from human serum.

Authors:  L BROMAN
Journal:  Nature       Date:  1958-12-13       Impact factor: 49.962

2.  Calcium phosphate chromatography of normal human serum and of electrophoretically isolated serum proteins.

Authors:  S HJERTEN
Journal:  Biochim Biophys Acta       Date:  1959-01

3.  A rapid colorimetric method for the quantitative determination of copper oxidase activity (ceruloplasmin).

Authors:  O B HOUCHIN
Journal:  Clin Chem       Date:  1958-12       Impact factor: 8.327

4.  Preparation of ceruloplasmin.

Authors:  M STEINBUCH; M QUENTIN
Journal:  Nature       Date:  1959-01-31       Impact factor: 49.962

5.  Preparation of ceruloplasmin.

Authors:  B E SANDERS; O P MILLER; M N RICHARD
Journal:  Arch Biochem Biophys       Date:  1959-09       Impact factor: 4.013

6.  Activation and other properties of ascorbic acid oxidase.

Authors:  E FRIEDEN; I W MAGGIOLO
Journal:  Biochim Biophys Acta       Date:  1957-04

7.  Cerebrocuprein I. A copper-containing protein isolated from brain.

Authors:  H PORTER; J FOLCH
Journal:  J Neurochem       Date:  1957       Impact factor: 5.372

8.  Concentration of ceruloplasmin in plasma of schizophrenic patients.

Authors:  I H SCHEINBERG; A G MORELL; R S HARRIS; A BERGER
Journal:  Science       Date:  1957-11-01       Impact factor: 47.728

9.  Oxidation of serotonin in the presence of ceruloplasmin.

Authors:  C C PORTER; D C TITUS; B E SANDERS; E V SMITH
Journal:  Science       Date:  1957-11-15       Impact factor: 47.728

10.  Effect of chymotrypsin on caeruloplasmin.

Authors:  G CURZON
Journal:  Nature       Date:  1958-01-11       Impact factor: 49.962

View more
  21 in total

1.  Studies on the oxidase properties of ceruloplasmin: factors in normal and Wilson's-disease serum affecting oxidase activity.

Authors:  J M WALSHE
Journal:  J Clin Invest       Date:  1963-07       Impact factor: 14.808

2.  Some properties of coupled iron-caeruloplasmin oxidation systems.

Authors:  G CURZON
Journal:  Biochem J       Date:  1961-06       Impact factor: 3.857

3.  The effects of some ions and chelating agents on the oxidase activity of caeruloplasmin.

Authors:  G CURZON
Journal:  Biochem J       Date:  1960-10       Impact factor: 3.857

4.  An investigation of the decolorization of caeruloplasmin by acid.

Authors:  G Curzon
Journal:  Biochem J       Date:  1965-10       Impact factor: 3.857

5.  Enzymic oxidation of 5-hydroxytryptamine by pig serum.

Authors:  H Blaschko; W G Levine
Journal:  J Physiol       Date:  1960-12       Impact factor: 5.182

6.  Simultaneous Cu-, Fe-, and Zn-specific detection of metalloproteins contained in rabbit plasma by size-exclusion chromatography-inductively coupled plasma atomic emission spectroscopy.

Authors:  Shawn A Manley; Simon Byrns; Andrew W Lyon; Peter Brown; Jürgen Gailer
Journal:  J Biol Inorg Chem       Date:  2008-09-10       Impact factor: 3.358

7.  Comparative effects of chelating drugs on trace metal and biochemical alterations in the rat.

Authors:  M Misra; M Athar; S K Hasan; R C Srivastava
Journal:  Bull Environ Contam Toxicol       Date:  1988-08       Impact factor: 2.151

8.  Demonstration of Paneth cell granules using Naphthalene Black.

Authors:  D Bower; C G Chadwin
Journal:  J Clin Pathol       Date:  1968-01       Impact factor: 3.411

9.  The inhibition of caeruloplasmin by azide.

Authors:  G Curzon
Journal:  Biochem J       Date:  1966-08       Impact factor: 3.857

10.  The binding of copper in human ceruloplasmin.

Authors:  E J Wood; D M Salisbuty; W H Bannister
Journal:  Experientia       Date:  1968-12-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.